AC
CGEM icon

AXQ Capital’s Cullinan Oncology CGEM Stock Holding History

AXQ Capital’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
+14,935
New +$222K 0.03% 636
2025
Q4 		– Sell
-32,669
Closed -$194K – 750
2025
Q3 		$194K Buy
+32,669
New +$239K 0.07% 458
2025
Q2 		– Sell
-14,255
Closed -$108K – 596
2025
Q1 		$108K Buy
+14,255
New +$137K 0.04% 438

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

AXQ Capital's CGEM Position: Q2 2026 in Review

AXQ Capital opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 14,935 shares worth $272K. The stake represents 0.03% of the portfolio and ranks #636 among its holdings. This is a return to the name: AXQ Capital previously reported a position in CGEM as recently as Q3 2025.

AXQ Capital first reported a position in CGEM in Q1 2025 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • AXQ Capital held 14,935 shares of Cullinan Oncology worth $272K as of Q2 2026.
  • Cullinan Oncology was a new AXQ Capital position in Q2 2026.
  • Cullinan Oncology made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #636 holding.
  • AXQ Capital first reported a position in Cullinan Oncology in Q1 2025 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.